These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32724793)

  • 1. A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19.
    Rahimi H; Tehranchinia Z
    Biomed Res Int; 2020; 2020():1236520. PubMed ID: 32724793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
    Galván Casas C; Català A; Carretero Hernández G; Rodríguez-Jiménez P; Fernández-Nieto D; Rodríguez-Villa Lario A; Navarro Fernández I; Ruiz-Villaverde R; Falkenhain-López D; Llamas Velasco M; García-Gavín J; Baniandrés O; González-Cruz C; Morillas-Lahuerta V; Cubiró X; Figueras Nart I; Selda-Enriquez G; Romaní J; Fustà-Novell X; Melian-Olivera A; Roncero Riesco M; Burgos-Blasco P; Sola Ortigosa J; Feito Rodriguez M; García-Doval I
    Br J Dermatol; 2020 Jul; 183(1):71-77. PubMed ID: 32348545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous manifestations in COVID-19: Lessons learned from current evidence.
    Suchonwanit P; Leerunyakul K; Kositkuljorn C
    J Am Acad Dermatol; 2020 Jul; 83(1):e57-e60. PubMed ID: 32339706
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are there cutaneous manifestations of SARS-CoV-2?].
    Drerup KA; Gläser R
    Hautarzt; 2020 Sep; 71(9):734-736. PubMed ID: 32778924
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic.
    Alam M; Lewis W; Harp J; Steele K; Rosenbach M; Micheletti RG
    Cutis; 2021 Apr; 107(4):209-215. PubMed ID: 34096848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID toes and other cutaneous manifestations of COVID-19.
    Rose-Sauld S; Dua A
    J Wound Care; 2020 Sep; 29(9):486-487. PubMed ID: 32924822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cutaneous manifestations in COVID-19: current state].
    Jazouly ME; Chahboun FZ; Chiheb S
    Pan Afr Med J; 2020; 35(Suppl 2):132. PubMed ID: 33193947
    [No Abstract]   [Full Text] [Related]  

  • 8. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatologic manifestations and complications of COVID-19.
    Gottlieb M; Long B
    Am J Emerg Med; 2020 Sep; 38(9):1715-1721. PubMed ID: 32731141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appearance of skin rash in pediatric patients with COVID-19: Three case presentations.
    Bursal Duramaz B; Yozgat CY; Yozgat Y; Turel O
    Dermatol Ther; 2020 Jul; 33(4):e13594. PubMed ID: 32412681
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.
    Sachdeva M; Gianotti R; Shah M; Bradanini L; Tosi D; Veraldi S; Ziv M; Leshem E; Dodiuk-Gad RP
    J Dermatol Sci; 2020 May; 98(2):75-81. PubMed ID: 32381430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous lesions in a patient with COVID-19: are they related?
    Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
    Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
    Marzano AV; Cassano N; Genovese G; Moltrasio C; Vena GA
    Br J Dermatol; 2020 Sep; 183(3):431-442. PubMed ID: 32479680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers.
    Mawhirt SL; Frankel D; Diaz AM
    Curr Allergy Asthma Rep; 2020 Oct; 20(12):75. PubMed ID: 33047260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and the Skin.
    Catalá Gonzalo A; Galván Casas C
    Actas Dermosifiliogr (Engl Ed); 2020; 111(6):447-449. PubMed ID: 32401723
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID-19.
    Llamas-Velasco M; Muñoz-Hernández P; Lázaro-González J; Reolid-Pérez A; Abad-Santamaría B; Fraga J; Daudén-Tello E
    Br J Dermatol; 2020 Sep; 183(3):591-593. PubMed ID: 32407552
    [No Abstract]   [Full Text] [Related]  

  • 17. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
    Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
    Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.
    Tang K; Wang Y; Zhang H; Zheng Q; Fang R; Sun Q
    Dermatol Ther; 2020 Jul; 33(4):e13528. PubMed ID: 32383234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
    Hughes M; Rogers S; Lepri G; Bruni C; Matucci-Cerinic M
    Br J Dermatol; 2020 Sep; 183(3):596-598. PubMed ID: 32460349
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
    Carrascosa JM; Morillas V; Bielsa I; Munera-Campos M
    Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):734-742. PubMed ID: 32882184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.